Short Interest in Prenetics Global Limited (NASDAQ:PRENW) Drops By 86.4%

Prenetics Global Limited (NASDAQ:PRENW) was the recipient of a significant decline in short interest in March. As of March 31st, there was short interest totaling 5,947 shares, a decline of 86.4% from the March 15th total of 43,726 shares. Based on an average trading volume of 4,506 shares, the days-to-cover ratio is currently 1.3 days.

Prenetics Global Stock Performance

Shares of PRENW stock traded down $0.00 on Friday, hitting $0.02. The stock had a trading volume of 51,500 shares, compared to its average volume of 20,548. The business has a 50 day moving average price of $0.02 and a 200 day moving average price of $0.02. Prenetics Global has a one year low of $0.01 and a one year high of $0.07.

About Prenetics Global

Prenetics Global (NASDAQ: PRENW) is a molecular diagnostics and preventive genomics company that develops and delivers DNA-based tests and diagnostic solutions. The company’s offerings include direct-to-consumer health profiling services, clinical genetic tests, and pathogen screening assays. By combining advanced laboratory processes with digital tools, Prenetics aims to provide insights into genetic risk factors, nutrition and fitness optimization, and early disease detection.

Prenetics operates a portfolio of consumer genomics brands, including DNAFit and CircleDNA, which offer personalized reports on wellness, exercise, nutrition, and inherited health traits.